Compare LEGN & FCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEGN | FCN |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.9B | 5.1B |
| IPO Year | 2020 | 1996 |
| Metric | LEGN | FCN |
|---|---|---|
| Price | $22.33 | $170.13 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 2 |
| Target Price | $69.67 | ★ $169.00 |
| AVG Volume (30 Days) | ★ 2.5M | 264.7K |
| Earning Date | 11-12-2025 | 10-23-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.77 |
| Revenue | $909,045,000.00 | ★ $3,693,035,000.00 |
| Revenue This Year | $68.83 | $1.50 |
| Revenue Next Year | $51.27 | $6.66 |
| P/E Ratio | ★ N/A | $21.66 |
| Revenue Growth | ★ 74.75 | N/A |
| 52 Week Low | $22.28 | $149.31 |
| 52 Week High | $45.30 | $204.76 |
| Indicator | LEGN | FCN |
|---|---|---|
| Relative Strength Index (RSI) | 21.96 | 61.18 |
| Support Level | $26.43 | $163.78 |
| Resistance Level | $28.97 | $170.92 |
| Average True Range (ATR) | 1.57 | 3.55 |
| MACD | -0.43 | 0.43 |
| Stochastic Oscillator | 0.91 | 93.06 |
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
FTI Consulting Inc is a firm that generates its sales by providing professional business advisory services to customers. The company operates through five segments, namely corporate finance, forensic and litigation consulting, economic consulting, technology, and strategic communications. The company generates the majority of its revenue from the Corporate finance segment. Customers of the company come from a wide array of sectors, including construction, energy and power, environmental, financial institutions, healthcare and life science, insurance, real estate and infrastructure, retail and consumer products, telecom, media, and technology. The majority of the company's revenue is derived from serving customers in the United States.